Nektar: Why Rezpeg Likely Won’t Replicate Its Eczema Success in Alopecia Areata
Nuvation Bio: IBTROZI’s Strong ROS1 Data vs. a Small Market and Big Expectations
Biotech 13F Season: What Baker Bros and RA Capital Are Quietly Telling You About the Sector
Pharvaris Aims to Reshape HAE Treatment with Oral Therapies
